CytomX Therapeutics, Inc.CTMXNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank0
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P0
Near historical low
vs 5Y Ago
-6.5x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-178.27%
2024485.49%
202393.60%
202212.67%
2021-44.08%
202027.37%
2019-42.40%
2018-68.34%
201722.37%
2016-79.46%